Hanall Biopharma Co.,Ltd (009420.KS) KSC
56,700.00
-1400(-2.41%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
56,700.00
-1400(-2.41%)
Currency In KRW
Address
Daewoong Building
Daejeon,
Korea (the Republic of)
Phone
+82 2 6440 7000
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
309
First IPO Date
January 04, 2000
| Name | Title | Pay | Year Born |
| Su-Jin Park | Co-CEO, VP & Director | 0 | 1972 |
| Sean Jeong | President, Co-CEO & Director | 0 | 1971 |
| SeongUn Kim | Head of Business Management Division | 0 | 1980 |
| Hye Kyung Ahn | Head of Research Division | 0 | 1971 |
| Nam-Yong Cho | Senior Executive Director of Sales & Marketing and Senior Managing Director | 0 | 1954 |
| Christopher W. Slavinsky | Chief Business Development & Legal Officer | 0 | 1973 |
| Jae-Seung Yoon | C.V.O | 0 | 1962 |
Hanall Biopharma Co.,Ltd, a pharmaceutical company, researches, develops, and sells pharmaceutical products in South Korea and internationally. The company offers specialty drugs and over-the-counter products for the treatment of gastric and duodenal ulcers, gastritis, cerebrovascular and peripheral blood vessel disorder, hypertension, atherosclerotic symptom, acute coronary syndrome, atherothrombosis and thromboembolism, diabetes, osteoporosis, chronic kidney failure, hypothyroidism, vitamin D-resistant rickets, osteomalacia, erectile dysfunction, prostatic hyperplasia, candidiasis, various fungal infections, prostate cancer, formal, constipation, thin stools, bloating, bowel abnormal fermentation, and hemorrhoids. The company was founded in 1973 and is based in Seoul, South Korea.